NBC Securities’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.3K Hold
250
﹤0.01% 1579
2025
Q4
$20.3K Sell
250
-183
-42% -$15.8K ﹤0.01% 1768
2025
Q3
$37.9K Hold
433
﹤0.01% 1443
2025
Q2
$35K Hold
433
﹤0.01% 1463
2025
Q1
$36K Buy
+433
New +$40.3K ﹤0.01% 1265
2024
Q4
Sell
-433
Closed -$40K 1733
2024
Q3
$40K Buy
433
+183
+73% +$15.9K ﹤0.01% 1239
2024
Q2
$20K Hold
250
﹤0.01% 1456
2024
Q1
$16K Hold
250
﹤0.01% 1530
2023
Q4
$14K Hold
250
﹤0.01% 1597
2023
Q3
$13K Buy
+250
New +$14.8K ﹤0.01% 1622

Other funds holding LMAT

NBC Securities's LMAT Position: Q1 2026 in Review

NBC Securities held its LeMaitre Vascular (LMAT) position steady in Q1 2026 at 250 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1579.

NBC Securities first reported a position in LMAT in Q3 2023 and has held it in 10 quarters since. The position peaked at $40K in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • NBC Securities held 250 shares of LeMaitre Vascular worth $27.3K as of Q1 2026.
  • NBC Securities left its LeMaitre Vascular share count unchanged in Q1 2026.
  • LeMaitre Vascular made up ﹤0.01% of NBC Securities's portfolio in Q1 2026, its #1579 holding.
  • NBC Securities first reported a position in LeMaitre Vascular in Q3 2023 and has held it in 10 quarters since.
  • NBC Securities's LeMaitre Vascular position peaked at $40K in Q3 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.